RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
about
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapyProgrammed necrosis in inflammation: Toward identification of the effector molecules.Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunityNew insights into the regulation of innate immunity by caspase-8.The oncolytic peptide LTX-315 triggers immunogenic cell death.The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease.Necroptosis: an alternative cell death program defending against cancer.Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.NF-κB functions as a molecular link between tumor cells and Th1/Tc1 T cells in the tumor microenvironment to exert radiation-mediated tumor suppression.Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control.Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency.Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors.Therapy-induced microenvironmental changes in cancer.Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.Cancer and necroptosis: friend or foe?The in vivo evidence for regulated necrosis.Lymph node - an organ for T-cell activation and pathogen defense.Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses.Necroptosis: A Novel Cell Death Modality and Its Potential Relevance for Critical Care Medicine.RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.More to Life than NF-κB in TNFR1 SignalingDying cells actively regulate adaptive immune responses.RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.Dendritic Cells and Cancer Immunity.Regulating the balance between necroptosis, apoptosis and inflammation by inhibitors of apoptosis proteins.Controlled detonation: evolution of necroptosis in pathogen defense.Relevance of necroptosis in cancer.Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.Necroptosis and Cancer.RIPK3 in cell death and inflammation: the good, the bad, and the ugly.RIPK3-driven cell death during virus infections.Initiation and execution mechanisms of necroptosis: an overview.Unusual antigen presentation offers new insight into HIV vaccine design.Necroptosis in cancer: An angel or a demon?Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI.The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.Culling of APCs by inflammatory cell death pathways restricts TIM3 and PD-1 expression and promotes the survival of primed CD8 T cells.
P2860
Q26739959-DC89EF9D-128F-4854-837E-4C22309C48E0Q34520528-FC9C96F5-A249-4B6E-A3AF-756F31317A7FQ36440299-55E9AD5A-ACB9-466C-9E79-5E47ADC3A5E6Q36477467-9EF58BA5-5A45-48B5-A4BE-46D68773F1A2Q36774984-38F45146-8BF8-4C16-9BB1-59B5826EDBBCQ36803448-AE9F5BB0-CFAA-4000-85D1-89B3CB8782EDQ36880118-17BC52C8-B516-46CF-AA18-9B65DD2C8671Q36880241-965144EF-5BD5-4218-B800-C55544C03C81Q37078968-D2195841-F040-4F1E-B46E-E84CDD9463F4Q37114367-3D7B6E13-2E6C-4954-B000-C9EF02C6F064Q37116056-EE048B2D-1DAE-4643-818A-945DC9A25C85Q37269029-5D662BB6-7E59-4D44-AC1A-B946DB57833FQ37688373-7BDA2FC0-C13A-4B1C-9ACF-DE1C677D2DECQ38605930-8B6B833F-62F2-4C51-9F5C-F0AD003F5060Q38657566-E84387BB-7F3A-448A-B6DC-58C0B8E2DEF4Q38756772-ECCE1CD1-3B46-4F19-BF6A-4A28449C29D2Q38779877-CDED5816-E00D-44A8-B908-F8ABF01744B4Q38799139-BEB89C4C-8BA6-4DDA-9505-7272F4156803Q38809791-99E36780-F7A4-4AED-9F4E-BA0E824011BCQ38810913-9F071AC7-E143-4AAC-BC19-41F7EA46A6E6Q38845953-2E13E92F-EA96-4FCB-B06F-D06B53C19F94Q38861198-CF929EE2-39C5-43A5-AB85-B181125750C6Q38862204-E5E16902-0D5D-4CD2-8167-A6434C6C7E6DQ38899361-5753ECA8-0CD6-424B-B697-006F074D3647Q38911753-285D7D40-68B9-4131-91B4-6B9ADF04EA31Q38984566-BC81E20E-8ED6-4294-AA01-3201A0A48284Q38994017-1489FACE-53AB-4D4F-9DFB-1039775FDEABQ39025072-7A1840AE-13D3-4FA7-8BBB-0C029A2A1864Q39026526-F823A127-6528-4298-85C4-F8CE27EA8EFEQ39030578-53CCE9E8-0132-451C-990D-2A4234751C1FQ39105381-8A03B03C-7230-4876-8AE2-BF0A1417EBAFQ39268644-EBD77002-9765-4CB8-B57E-DD3DCFA65E2CQ39277433-63A847E6-9763-463E-9898-5F16FE908FC8Q39277453-37818E5A-F923-4B00-80AC-0F7914FAD7A0Q39302537-D5ED9E93-54B6-4AC9-97AC-AA4B7D6E953DQ39307257-987262E5-442A-4FA6-90FB-F348CAE0EB39Q39398933-AC06D1D8-5CA0-4519-9132-F217179191B6Q39648552-6F9CDE79-A04E-48FD-B39D-C6A956D3317FQ39740446-FE187773-8FAA-43DC-AC16-3776A78E0648Q40144211-325ACED8-6AAD-4C0B-A39D-67FF63814B85
P2860
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
@ast
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
@en
type
label
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
@ast
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
@en
prefLabel
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
@ast
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.
@en
P2093
P2860
P50
P356
P1433
P1476
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells
@en
P2093
Andrew Oberst
Hélène Jusforgues-Saklani
Matthew L Albert
Nader Yatim
Oliver Schulz
Rosa Barreira da Silva
P2860
P304
P356
10.1126/SCIENCE.AAD0395
P407
P577
2015-09-24T00:00:00Z